enVVeno Medical (NVNO) News Today $3.77 -0.05 (-1.31%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$3.82 +0.04 (+1.19%) As of 02/21/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period enVVeno Medical (NASDAQ:NVNO) Shares Up 6.4% - Here's WhyenVVeno Medical (NASDAQ:NVNO) Trading 6.4% Higher - What's Next?February 22 at 12:49 AM | marketbeat.comenVVeno Medical presents one-year data from VenoValve trialFebruary 20 at 5:57 PM | markets.businessinsider.comVenoValve trial shows sustained patient benefits at 24 monthsFebruary 7, 2025 | msn.comenVVeno Medical presents two-year follow-up data from VenoValve trialFebruary 7, 2025 | markets.businessinsider.comWestside Investment Management Inc. Acquires 116,650 Shares of enVVeno Medical Corporation (NASDAQ:NVNO)Westside Investment Management Inc. grew its holdings in enVVeno Medical Corporation (NASDAQ:NVNO - Free Report) by 132.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 205,025 shares of the compJanuary 22, 2025 | marketbeat.comInsider Buying: enVVeno Medical Corporation (NASDAQ:NVNO) Director Acquires 3,500 Shares of StockJanuary 3, 2025 | insidertrades.comenVVeno Medical Corporation (NASDAQ:NVNO) Director Robert Gray Buys 3,500 SharesenVVeno Medical Corporation (NASDAQ:NVNO - Get Free Report) Director Robert Gray bought 3,500 shares of the business's stock in a transaction dated Tuesday, December 31st. The shares were bought at an average price of $2.94 per share, with a total value of $10,290.00. Following the purchase, the director now owns 11,155 shares in the company, valued at $32,795.70. The trade was a 45.72 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.January 2, 2025 | marketbeat.comInsider Buying: enVVeno Medical Corporation (NASDAQ:NVNO) Director Purchases 5,400 Shares of StockDecember 27, 2024 | insidertrades.comenVVeno Medical Corporation (NASDAQ:NVNO) Director Acquires $15,660.00 in StockenVVeno Medical Corporation (NASDAQ:NVNO - Get Free Report) Director Sanjay Shrivastava purchased 5,400 shares of the firm's stock in a transaction dated Tuesday, December 24th. The shares were bought at an average cost of $2.90 per share, for a total transaction of $15,660.00. Following the completion of the purchase, the director now directly owns 9,288 shares of the company's stock, valued at $26,935.20. The trade was a 138.89 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.December 26, 2024 | marketbeat.comenVVeno Medical Corporation (NASDAQ:NVNO) Director Acquires $24,338.60 in StockDecember 24, 2024 | insidertrades.comenVVeno Medical Corporation: enVVeno Medical Successfully Completes Final Wave of Implants in Pre-Clinical GLP Study for enVVeDecember 16, 2024 | finanznachrichten.deenVVeno Medical to Present Definitive One Year Data from the VenoValve U.S. Pivotal Trial Today at the 51st Annual VEITH SymposiumNovember 20, 2024 | finance.yahoo.comenVVeno Medical Corporation: enVVeno Medical Submits the VenoValve PMA Application Seeking FDA ApprovalNovember 19, 2024 | finanznachrichten.deenVVeno Medical reports Q3 EPS (35c) vs. (45c) last yearNovember 1, 2024 | markets.businessinsider.comenVVeno Medical expects capital to fund company through several milestonesNovember 1, 2024 | markets.businessinsider.comenVVeno Medical Successfully Initiates 6-Month Pre-Clinical GLP Study Evaluating enVVe(R)October 28, 2024 | finance.yahoo.comAVITA Medical Headed For Its Most Important Report, I'm Extremely BullishOctober 2, 2024 | seekingalpha.comBioMedNewsBreaks — enVVeno Medical Corporation (NASDAQ: NVNO) Announces Pricing of $15M Underwritten Public OfferingOctober 1, 2024 | msn.comenVVeno Medical (NASDAQ:NVNO) Stock Quotes, Forecast and News SummarySeptember 28, 2024 | benzinga.comCrude Oil Rises; Onconetix Shares Spike HigherSeptember 27, 2024 | msn.comCassava Sciences, enVVeno Medical And Other Big Stocks Moving Lower In Friday's Pre-Market SessionSeptember 27, 2024 | msn.comEnVVeno Medical Announces Pricing Of Public Offering - Quick FactsSeptember 27, 2024 | markets.businessinsider.comenVVeno Medical Corporation Announces Proposed Public OfferingSeptember 27, 2024 | finance.yahoo.comenVVeno Medical Corporation: enVVeno Medical Adds Sandy Prietto to its Executive Team as Vice President of MarketingSeptember 4, 2024 | finanznachrichten.deVanguard Group Inc. Buys 237,550 Shares of enVVeno Medical Corporation (NASDAQ:NVNO)Vanguard Group Inc. raised its position in shares of enVVeno Medical Corporation (NASDAQ:NVNO - Free Report) by 70.6% in the first quarter, according to its most recent filing with the SEC. The firm owned 573,955 shares of the company's stock after purchasing an additional 237,550 shares during theAugust 19, 2024 | marketbeat.comenVVeno Medical Corporation Registered ShsJuly 19, 2024 | markets.businessinsider.comKingdon Capital Management L.L.C. Purchases 400,000 Shares of enVVeno Medical Corporation (NASDAQ:NVNO)Kingdon Capital Management L.L.C. increased its holdings in shares of enVVeno Medical Corporation (NASDAQ:NVNO - Free Report) by 182.5% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 619,180 shares of the company's stock after purchasing an additional 40June 17, 2024 | marketbeat.comenVVeno Medical Corporation (NASDAQ:NVNO) Stake Lessened by Perceptive Advisors LLCPerceptive Advisors LLC trimmed its stake in shares of enVVeno Medical Corporation (NASDAQ:NVNO - Free Report) by 20.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 623,315 shares of the company's stock after sellinJune 16, 2024 | marketbeat.comArmistice Capital LLC Invests $2.24 Million in enVVeno Medical Corporation (NASDAQ:NVNO)Armistice Capital LLC purchased a new position in enVVeno Medical Corporation (NASDAQ:NVNO - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 436,000 shares of the company's stock, valued at approximatelyJune 6, 2024 | marketbeat.comenVVeno Medical (NASDAQ:NVNO) Trading Down 1.8%enVVeno Medical (NASDAQ:NVNO) Trading Down 1.8%May 22, 2024 | marketbeat.comNVNO Stock Earnings: enVVeno Medical Beats EPS for Q1 2024May 9, 2024 | msn.comenVVeno Medical Reports First Quarter 2024 Financial Results and Provides Corporate UpdateMay 8, 2024 | finance.yahoo.comenVVeno Medical Corporation (NVNO)April 24, 2024 | finance.yahoo.comPositive 11 Month Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical's VenoValve(R) Pivotal Trial to be Presented Today at the 46th Annual Charing Cross SymposiumApril 24, 2024 | finance.yahoo.comNew Topline Efficacy Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the 46th Annual Charing Cross Symposium on April 24, 2024April 16, 2024 | finance.yahoo.comenVVeno Medical hires new CCO to guide transitionApril 11, 2024 | uk.investing.comenVVeno Medical Corporation: enVVeno Medical Appoints Andrew Cormack as Its Chief Commercial OfficerApril 10, 2024 | finanznachrichten.deenVVeno Medical Appoints Andrew Cormack as Its Chief Commercial OfficerApril 9, 2024 | finance.yahoo.comenVVeno Medical Corporation (NASDAQ:NVNO) CTO Hamed Alavi Sells 8,334 SharesMarch 16, 2024 | insidertrades.comNVNO Apr 2024 10.000 callMarch 16, 2024 | finance.yahoo.comenVVeno Medical to Participate in the Virtual Investor Lunch Break: The enVVeno OpportunityMarch 15, 2024 | finance.yahoo.comPositive Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical’s VenoValve(R) Pivotal Trial to be Presented Today at the VENOUS2024 American Venous Forum Annual MeetingMarch 6, 2024 | finance.yahoo.comCompanies Like enVVeno Medical (NASDAQ:NVNO) Are In A Position To Invest In GrowthMarch 3, 2024 | finance.yahoo.comenVVeno Medical Corporation: enVVeno Medical Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate UpdateFebruary 29, 2024 | finanznachrichten.deRecap: enVVeno Medical Q4 EarningsFebruary 29, 2024 | benzinga.comenVVeno Medical Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate UpdateFebruary 29, 2024 | finance.yahoo.comTopline Efficacy Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the VENOUS2024 American Venous Forum Annual Meeting on March 6, 2024February 20, 2024 | finance.yahoo.comenVVeno Medical (NVNO) Scheduled to Post Quarterly Earnings on MondayenVVeno Medical (NASDAQ:NVNO) will be releasing earnings on Monday, February 5, Yahoo Finance reports.February 4, 2024 | marketbeat.comenVVeno Medical Corporation's (NASDAQ:NVNO) Path To ProfitabilityJanuary 6, 2024 | finance.yahoo.comNVNO Jan 2024 5.000 callDecember 29, 2023 | ca.finance.yahoo.com Get enVVeno Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for NVNO and its competitors with MarketBeat's FREE daily newsletter. Email Address NVNO Media Mentions By Week NVNO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVNO News Sentiment▼0.260.60▲Average Medical News Sentiment NVNO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVNO Articles This Week▼20▲NVNO Articles Average Week Get enVVeno Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for NVNO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies KRMD News OBIO News UTMD News BWAY News SKIN News PROF News INFU News TLSI News SGHT News LNSR News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NVNO) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding enVVeno Medical Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share enVVeno Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NVNO Stock Alerts